BRAF and metastatic neoplasm: Conversely, BRAF-WT CMV+ patients presenting with metastatic disease were a mean 9.0 yr older than seronegative counterparts (95% CI, 3.0 to 13.0 yr; P = 1.3 × 10−4, Wilcoxon rank sum test; Fig. 6c).